Show simple item record

dc.contributor.authorBarkoff, Alex-Mikael
dc.contributor.authorMertsola, Jussi
dc.contributor.authorPierard, Denis
dc.contributor.authorDalby, Tine
dc.contributor.authorHoegh, Silje Vermedal
dc.contributor.authorGuillot, Sophie
dc.contributor.authorStefanelli, Paola
dc.contributor.authorvan Gent, Marjolein
dc.contributor.authorBerbers, Guy
dc.contributor.authorVestrheim, Didrik
dc.contributor.authorGreve-Isdahl, Margrethe
dc.contributor.authorWehlin, Lena
dc.contributor.authorLjungman, Margaretha
dc.contributor.authorFry, Norman K
dc.contributor.authorMarkey, Kevin
dc.contributor.authorHe, Qiushui
dc.date.accessioned2019-03-22T08:14:03Z
dc.date.available2019-03-22T08:14:03Z
dc.date.issued2019-02-01
dc.identifier.issn1560-7917
dc.identifier.pmid30782265
dc.identifier.doi10.2807/1560-7917.ES.2019.24.7.1700832
dc.identifier.urihttp://hdl.handle.net/10029/622889
dc.description.abstractIntroductionPertussis outbreaks have occurred in several industrialised countries using acellular pertussis vaccines (ACVs) since the 1990s. High prevalence of pertactin (PRN)-deficienten_US
dc.language.isoenen_US
dc.subjectacellular vaccineen_US
dc.subjectpertactinen_US
dc.subjectpertussisen_US
dc.subjectvaccination, Europeen_US
dc.titlePertactin-deficient isolates: evidence of increased circulation in Europe, 1998 to 2015.en_US
dc.typeArticleen_US
dc.identifier.journalEuro Surveill 2019; 24(7):pii.1700832en_US
dc.source.journaltitleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin


This item appears in the following Collection(s)

Show simple item record